TrueBeam 3.0 radiotherapy system installed in Jalandhar, first for the state

The Patel Hospital, Jalandhar, has announced the installation of the TrueBeam 3.0 Linear Accelerator, making it the first hospital in Punjab to upgrade to this state-of-the-art radiotherapy technology. The advancement is aimed at Patel Hospital’s continued mission of providing world class cancer treatment, backed by precision, safety and compassion.

Dr Shikha Chawla, Head, Department of Radiotherapy at the hospital, said, “A state-of-the-art tool for radiotherapy, the TrueBeam 3.0 represents the gold standard in modern radiation oncology.

It delivers treatment with sub-millimeter precision, enabling clinicians to target cancer cells with unprecedented accuracy while protecting surrounding healthy tissues. The system also introduces RapidArc technology, allowing treatments to be delivered in a fraction of time, significantly improving patient comfort and efficiency.”

The key benefits of TrueBeam 3.0 include: Unmatched precision and accuracy which involves sub-millimeter targeting for better outcomes; faster, comfortable treatments and reduced session times for patient convenience; advanced imaging for real-time accuracy, which includes 4D CBCT, iterative CBCT, triggered imaging, and MV/KV radiographs synchronised with patient breathing and built-in safety protocols wherein Maestro Synchronous Control System enhances treatment reliability.

Dr Chawla said, “With a legacy of 50 years of excellence, we have always aimed at the provision of new breakthroughs in cancer treatment for patients.

Patel Hospital holds the distinction of being among the comprehensive cancer care centres in the country offering medical oncology, radiation oncology, surgical oncology and nuclear medicine under one roof.

The addition of TrueBeam 3.0 further strengthens the hospital’s commitment to the provision of advanced healthcare and innovation.”

She added, “TrueBeam 3.0 is a milestone not just for cancer care but also Punjab and the northern region. Patients will benefit from treatments that are safer, faster and more effective, reflecting our commitment to staying at the cutting-edge of medical advancements.”